BioSpace News Archive

Pegasystems Inc. announced it has been named a Leader in the Forrester Research report, The Forrester WaveTM : Healthcare CRM Providers, Q1 2020.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that on March 13, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for its diagnostic test that can be used immediately by CLIA high-complexity laboratories in the U.S. to detect nucleic acid from SARS-CoV-2,

Ardelyx, Inc. (NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today announced that Onaiza Cadoret-Manier, an industry veteran with deep biopharmaceutical commercial experience, has joined the Company’s Board of Directors

Kaiser Permanente is providing $1 million to increase capacity for preventing and treating cases of COVID-19, the disease caused by the novel coronavirus, within the nation’s homeless population in a collaboration with the National Health Care for the Homeless Council.

Endologix® Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that it has received approval from the United States Food and Drug Administration (FDA) for the Alto™ Abdominal Stent Graft System (Alto).

Celavet has previously collaborated with Dr. Watts to evaluate OK100 stem cells for treatment of equine tendon injuries

Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has completed the non-cash transaction of the transition of Oncometrix’s customer base, as discussed in Precipio’s recent announcement.

Millennium Dental Technologies, Inc., announces limited-time dynamic pricing on the PerioLase® Periodontal Package™ for the LANAP® protocol, LAPIP™ protocol, and VAPs™.

DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that SKIN, the official journal of the National Society for Cutaneous Medicine, has published data showing that combining TERT DNA mutation analyses with DermTech’s Pigmented Lesion Assay (the “DermTech PLA”) improved the test sensitivity for detecting melanoma to 97%, up from a sensitivity of 91% without TERT.

Jvion, a leader in clinical AI, announced that it has initiated a data analysis project to identify patterns tied to the spread of viruses similar to COVID-19 that cause acute respiratory illness.